Anti‐amyloid‐β treatment effects on dominantly inherited Alzheimer disease neuropathology: comparing autopsy findings with biomarker outcomes from the DIAN‐TU‐001 trial of gantenerumab or solanezumab.
Saved in:
| Title: | Anti‐amyloid‐β treatment effects on dominantly inherited Alzheimer disease neuropathology: comparing autopsy findings with biomarker outcomes from the DIAN‐TU‐001 trial of gantenerumab or solanezumab. |
|---|---|
| Authors: | Chen, Charles D., Franklin, Erin E., Li, Yan, Joseph‐Mathurin, Nelly, Burns, Aime, Hobbs, Diana A, McCullough, Austin A., Schultz, Stephanie A., Wang, Guoqiao, Benzinger, Tammie L.S., Bateman, Randall J., Perrin, Richard J. |
| Source: | Alzheimer's & dementia: the journal of the Alzheimer's Association Dec2024 Supplement; Vol. 20 (S8). |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 1552-5260 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.095436 |
